A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study)

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
E BouzaCooperative Group of the European Study Group on Nosocomial Infections (ESGNI)

Abstract

The laboratory workload, microbiological techniques and aetiology of catheter-related infections in European hospitals are mostly unknown. The present study (ESGNI-005) comprised a 1-day (22 October 2001), laboratory-based, point-prevalence survey based on a questionnaire completed by microbiology laboratories in European (European Union (EU) and non-EU) hospitals. Also included were questions requesting retrospective information for the year 2000. In total, 151 hospitals from 26 European countries participated, of which 78.1% were teaching institutions. Overall, the estimated population served by these institutions was 121,363,800, and the estimated number of admissions during 2000 was 6,712,050. The total number of catheter tips processed during 2000 was 142,727, or 21/1,000 admissions, of which 23.7% were considered to be positive in the institutions using semiquantitative or quantitative techniques. Overall, EU centres received significantly more catheter tip samples/1,000 admissions and had a significantly higher rate of 'positivity' (p < 0.0001) than non-EU centres. Of the institutions surveyed, 11.4% (7.2% in EU countries and 23.7% in non-EU countries; p 0.04) used only qualitative techniques for catheter tip sample proc...Continue Reading

References

May 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A CapdevilaJ M Martínez-Vázquez
Jul 1, 1990·Archives of Internal Medicine·E CercenadoE Bouza
May 1, 1990·Diagnostic Microbiology and Infectious Disease·R G Nahass, M P Weinstein
Feb 1, 1997·The Journal of Hospital Infection·P GastmeierH Rüden
Feb 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·D PittetA Widmer
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Apr 9, 2002·Journal of Chemotherapy·G DonelliUNKNOWN CVC Study Group
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·O LyytikäinenUNKNOWN Hospital Infection Surveillance Team
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bart J A RijndersWilly E Peetermans

❮ Previous
Next ❯

Citations

Feb 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emilio BouzaPatricia Muñoz
Mar 19, 2013·The Journal of Hospital Infection·J ColstonI C J W Bowler
Dec 7, 2010·International Journal of Antimicrobial Agents·Leonidia Leonidou, Charalambos A Gogos
Jan 8, 2008·Diagnostic Microbiology and Infectious Disease·Thomas R FritscheRonald N Jones
May 28, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·E D OlthofG J A Wanten
Apr 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Rodríguez-CréixemsE Bouza
Jun 7, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Felipe Francisco TuonJuliette Cielinski
Sep 27, 2007·Microbiology and Immunology·André Martins, Maria de Lourdes R S Cunha
Jun 27, 2006·Scandinavian Journal of Infectious Diseases·Christina Agvald-OhmanCharlotta Edlund
Feb 6, 2020·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Beatriz AlonsoMaría Guembe
Oct 18, 2007·Wiener klinische Wochenschrift·Ines Schwetz, Krause Robert
Aug 2, 2019·Infectious Diseases and Therapy·Keita TatsunoKyoji Moriya
Jul 4, 2021·Diagnostic Microbiology and Infectious Disease·Pilar CatalánUNKNOWN Gregorio Marañón Microbiology-ID COVID 19 Study Group
Aug 19, 2005·Revista iberoamericana de micología·Eric Moisés Flores-RuizHumberto Díaz-Ponce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
E BouzaP Muñoz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
E BouzaP Muñoz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Leonard A MermelDavid K Warren
Journal of Clinical Microbiology
Hans-Jörg LindeNorbert Lehn
© 2021 Meta ULC. All rights reserved